Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.
Saved in:
| Title: | Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma. |
|---|---|
| Authors: | Shi, Wenhao1 (AUTHOR), Tang, Haotian1,2 (AUTHOR), Tong, Linjiang2 (AUTHOR), Song, Peiran1 (AUTHOR), Huang, Yuqing1 (AUTHOR), Wan, Zhipeng1 (AUTHOR), Huang, Gege1 (AUTHOR), Liu, Qiupei1,3 (AUTHOR), Zhan, Zhengsheng4 (AUTHOR), Zhou, Yu1 (AUTHOR), Li, Yuantong1 (AUTHOR), Wen, Jiaxin1,2 (AUTHOR), Tang, Bencan3 (AUTHOR), Duan, Wenhu4 (AUTHOR), Ding, Jian2 (AUTHOR), Li, Xiaorui5 (AUTHOR) xiaorui_li@126.com, Xie, Hua1,2 (AUTHOR) hxie@simm.ac.cn |
| Source: | Cancer Cell International. 7/25/2025, Vol. 25 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
